This supplement will review the technology, data and clinical experiences using the MyoSure® Hysteroscopic Tissue Removal System (Myosure Tissue Removal System).
Revolutionizing Hysteroscopic Tissue Removal Using the MyoSure® System
Abnormal uterine bleeding affects approximately 30% of women. Ultimately, direct visualization via hysteroscopy is known to provide a minimally invasive approach to visualize the endometrial cavity and enable subsequent removal of structural uterine lesions using electrosurgical loop or hysteroscopic morcellation. This supplement will review the technology, data and clinical experiences using the MyoSure® Hysteroscopic Tissue Removal System (Myosure Tissue Removal System).
HP-hMG stimulation reduces OHSS risk in high responder patients
October 25th 2024A recent study found that highly purified human menotropin significantly lowers the risk of ovarian hyperstimulation syndrome compared to recombinant follicle stimulating hormone, highlighting the benefits of protocol individualization based on gonadotropin type.
Read More